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Abstract objective To review the findings of studies of pharyngeal carriage of Neisseria meningitidis and
related species conducted in the African meningitis belt since a previous review published in 2007.
methods PubMed and Web of Science were searched in July 2018 using the terms ‘meningococcal OR
Neisseria meningitidisOR lactamica AND carriage AND Africa’, with the search limited to papers
published on or after 1st January 2007. We conducted a narrative review of these publications.
results One hundred and thirteen papers were identified using the search terms described above, 20
of which reported new data from surveys conducted in an African meningitis belt country. These
papers described 40 surveys conducted before the introduction of the group A meningococcal
conjugate vaccine (MenAfriVacR) during which 66 707 pharyngeal swabs were obtained. Carriage
prevalence of N. meningitidis varied substantially by time and place, ranging from <1% to 24%. The
mean pharyngeal carriage prevalence of N. meningitidis across all surveys was 4.5% [95% CI: 3.4%,
6.8%] and that of capsulated N. meningitidis was 2.8% [95% CI: 1.9%; 5.2%]. A study of
households provided strong evidence for meningococcal transmission within and outside households.
The introduction of MenAfriVac led to marked reductions in carriage of the serogroup A
meningococcus in Burkina Faso and Chad.
conclusions Recent studies employing standardised methods confirm the findings of older studies that
carriage ofN. meningitidis in the African meningitis belt is highly variable over time and place, but
generally occurs with a lower prevalence and shorter duration than reported from industrialised countries.
keywords Neisseria meningitidis, meningococcal carriage, African meningitis belt
Introduction
Only a very small proportion of infections caused by
Neisseria meningitidis progress to invasive meningococcal
disease, the majority resulting in an asymptomatic, or
only mildly symptomatic, infection of the pharynx. Study
of pharyngeal meningococcal carriage is, therefore, essen-
tial for a full understanding of the epidemiology of this
infection [1]. Furthermore, there is now good evidence
that the impact of serogroups A and C meningococcal
conjugate vaccines is due in a large part to their ability
to prevent carriage [2–6]. Therefore, there has been a
renewed interest in pharyngeal carriage of Neisseria spe-
cies in the African meningitis belt where the greatest bur-
den of meningococcal disease still occurs.
A review of studies of meningococcal carriage con-
ducted in the African meningitis belt between 1915 and
2007 was published in 2007 [7]. This review noted large
variations in meningococcal carriage prevalence and ser-
ogroup between places and over time. How much of this
variation was due to differences in the field techniques
used to collect specimens and/or in the laboratory meth-
ods used to analyse these samples, and how much was a
reflection of true variation in the epidemiology of this
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infection, were uncertain. Since 2007, additional studies
of meningococcal carriage have been undertaken in coun-
tries of the African meningitis belt using similar, more
standardised, field and laboratory methods. A narrative
review of these studies and the ways in which their find-
ings contribute to our understanding of the overall epi-
demiology of N. meningitidis are presented here.
Methods
We searched PubMed and Web of Science on 4th July
2018 using the terms ‘meningococcal OR Neisseria menin-
gitidis OR lactamica AND carriage AND Africa’, restrict-
ing our search to papers published on or after 1st January
2007 (Figure 1). This search identified 113 papers, 20 of
which reported new data on meningococcal carriage in
representative populations in countries of the African
meningitis belt (Table S1). No further relevant documents
from the grey literature were found on the System for
Information on Grey Literature in Europe (SIGLE).
Results
Twenty papers were identified which described meningo-
coccal carriage surveys conducted in nine African menin-
gitis belt countries and reported since 2007 [4–6, 8–24].
Sixteen of these surveys were conducted prior to the
deployment of the group A meningococcal conjugate vac-
cine (MenAfriVac). Three additional papers reported
specifically on methods used in the MenAfriCar [25, 26]
and Burkina Faso [27] studies. The methods used in these
studies and their findings are summarised in this paper.
Methods
Selection of study participants. Participants were selected
for the 20 surveys conducted by the MenAfriCar Consor-
tium randomly from within a population defined either
through an established Demographic Surveillance System
(DSS) or from a population census [25]. A random sam-
ple of subjects in each of four age categories (0–4, 5–14,
15–29 and ≥30 years) was chosen within selected house-
holds. In Burkina Faso, surveys were conducted in both
rural and urban areas. In the rural districts, 10 villages
were selected based on probability proportional to size,
and within each village households were chosen ran-
domly using Global Positioning System coordinates. In
the urban district, city blocks were randomly chosen
based on existing maps and all subjects living in selected
households were invited to participate. In Ethiopia, a
DSS was used to select a random sample of subjects in a
region different from that studied by the MenAfriCar
Consortium [18]. In the remainder of the studies, a con-
venience sample was used.
The majority of surveys were restricted to subjects aged
1–29; only the studies conducted by the MenAfriCar
Consortium included subjects in all age groups including
infants.
Swabbing technique. Since the time of the 2007 review
[7], standardisation of swabbing techniques has improved
with nearly all surveys undertaking swabbing of the back
of the throat using a swab introduced through the mouth.
This approach was used in all the studies reviewed except
for one survey [23], which used swabbing of the posterior
nasopharynx with a swab introduced through the nose,
the technique used most frequently for surveys of pneu-
mococcal carriage. Among studies that used the oropha-
ryngeal approach, swabbing of solely the posterior
pharyngeal wall was used in two studies whilst in the
remainder both the posterior pharynx and the tonsils
were swabbed. A comparative study conducted in Mali
showed no significant difference in the prevalence of pha-
ryngeal carriage of N. meningitidis using either of these
two methods [26].
Identification of Neisseria meningitidis. Swabs were
inoculated directly onto selective agar plates in all but
one study, which employed transport medium [23], and
plates were incubated within a maximum of 6 h after
swabbing. The most widely used selective medium was
Modified Thayer Martin containing vancomycin, col-
istin, nystatin and trimethoprim. Plates were incubated
for 24–48 h at 37 °C in a 5% CO2 atmosphere.
All studies relied initially on conventional microbiologi-
cal approaches to identify Neisseria species. An alterna-
tive method of identifying meningococcal carriage was
evaluated in The Gambia; culture of the swab in Todd-
Hewitt broth followed by DNA extraction and quantita-
tive real-time PCR. This method had a higher sensitivity
than conventional microbiological methods [20].
Serogrouping was performed initially by slide aggluti-
nation. Six of the seven countries involved in the MenA-
friCar studies used PCR to confirm the identity of
N. meningitidis isolates and to identify the genes coding
for the capsule [25]. Confirmatory analyses and molecu-
lar characterisation were performed in external laborato-
ries in Europe. Most studies also reported the variants of
the two outer membrane proteins PorA and FetA. Studies
in Burkina Faso and Ethiopia reported sequence types
[14, 22] and the most recent studies also used whole gen-
ome sequencing (WGS) [21, 22].
A laboratory quality control system was established for
the later carriage studies conducted in Burkina Faso [27]
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and a similar quality control scheme was employed in the
MenAfriCar Consortium studies.
The prevalence of pharyngeal carriage and the dominant
serogroup/genogroup prior to vaccination with MenAfri-
Vac. The prevalence of pharyngeal carriage identified
in 40 surveys undertaken prior to the introduction of
MenAfriVac, and the dominant N. meningitidis ser-
ogroup/genogroup, identified in these surveys, are sum-
marised in Table 1. Twenty-nine of these studies were
conducted by members of the MenAfriCar consortium.
Both the overall prevalence of carriage and the dominant
serogroup/genogroup varied substantially among sites
studied at the same time, and at the same site studied at
different times. The mean prevalence of pharyngeal
meningococcal carriage in 66,707 pharyngeal swabs
obtained during 40 carriage surveys was 4.5% [95% CI:
3.4%, 6.8%], varying between surveys from <1% to
24.1%; however, in only six surveys was the meningo-
coccal carriage prevalence 10% or greater (Table 1). In
most surveys, capsulated meningococci (mean prevalence
2.8% [95% CI: 1.9%; 5.2%]) were more prevalent than
non-capsulated meningococci (mean prevalence 1.8%
[95% CI: 1.0%, 2.4%]) (Table 1) but the proportion of
non-capsulated meningococci varied substantially among
sites and over time. The highest prevalence of non-capsu-
lated meningococci was found in Ethiopia [18].
The highest carriage rate reported (24.1%) among the
studies conducted by the MenAfriCar Consortium was
from a rural community in Senegal predominantly due to
a sudden increase in the prevalence of carriage with ser-
ogroup W meningococci (NmW) [25]. Serogroup Y
meningococci (NmY) predominated in one area of Ethio-
pia [16] and NmX and NmY in another area of the same
country [18]. A predominance of serogroup A meningo-
cocci (NmA) was detected only in Chad in 2010 and
2011 [18] and in Burkina Faso in 2006 [11]; these three
surveys were undertaken at the time of a serogroup A
epidemic. The prevalence of carriage of NmA in Chad
was only about 1%, even though a major epidemic was
occurring [4]. In Burkina Faso, significant differences in
the carriage prevalence were observed between nearby
villages [12] and the same variation in patterns of car-
riage over short distances was noted in Ethiopia [18].
Transmission of N. meningitidis within households. A
pilot study of household transmission in Mali recruited
20 households and followed them for 6 months prior to
MenAfriVacR introduction, followed by a further three,
monthly visits 10 months after vaccination [24]. The
acquisition rate of meningococci was 2.3 per 100 individ-
uals per month and the mean duration of carriage was
2.9 months. A large majority of isolates in this study
were non-capsulated.
In a subsequent larger study conducted in five countries
by members of the MenAfriCar consortium, a pharyngeal
swab was collected from consenting household members
within a month of detection of an index carrier and then
at fortnightly intervals for 2 months and then monthly
for a further 6 months [19]. In 51 households, the initial
identification of a meningococcal carrier was not con-
firmed by molecular characterisation and these house-
holds formed a control group. One hundred and fifty-two
(20.6%) of the 739 residents of households with an ini-
tial carrier acquired a meningococcus during the
6 months of follow-up compared with 35/371 (9.4%) of
residents of control households (P < 0.001). Transmission
from sibling to sibling was the most frequent pattern of
household transmission. The mean duration of carriage
was 3.4 months and only 20 individuals carried meningo-
cocci for the full 6-month period of follow-up [19].
Risk factors for carriage of N. meningitidis. Six studies
conducted by independent groups of investigators
reported on risk factors for the prevalence of pharyngeal
carriage of N. meningitidis and one study investigated
risk factors for acquisition (Table 2) [6, 9, 18, 22, 23].
Age was a strong risk factor for carriage, with the preva-
lence of carriage peaking in those aged 5–14 years in
nearly all surveys. Carriage was more frequent in males
than in females. Other risk factors varied between sur-
veys (Table 2) but included (i) the presence of an internal
kitchen or a cigarette smoker in the household; (ii) house-
hold crowding; (iii) a recent respiratory infection (iv) liv-
ing in a rural environment and (v) a past history of
vaccination with a polysaccharide meningococcal vaccine.
The latter was an unexpected finding, which may have
been due in part to the fact that polysaccharide vaccina-
tion, which has little or no impact on carriage, is likely
to have focussed on those communities most at risk. In
four studies, a 50% increase in carriage was detected in
the dry season compared to the rainy season and a simi-
lar increase was noted in a further unpublished study
from Burkina Faso (Kristiansen, personal communica-
tion).
Blood samples collected in the household study
described above allowed an evaluation of the association
between serum bactericidal antibody (SBA) concentration
and acquisition of carriage during the following
6 months. Sufficient episodes of transmission of NmW
and NmY occurred within the study households to allow
correlations to be made between SBA titre to NmW and
NmY and acquisition of carriage with meningococci of
the respective serogroup. No correlation was found, even
© 2018 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 145
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though some subjects had high SBA titres in the range of
those found following vaccination [28].
Impact of MenAfriVacR on the prevalence of car-
riage. Because of the infrequent detection of NmA dur-
ing the period of the studies conducted since 2007, it was
possible to study the impact of the MenAfriVacR on car-
riage of NmA in only two countries (Figure 2). In Burk-
ina Faso, the carriage prevalence of NmA was low before
the introduction of the vaccine (<1%) but fell to zero a
month after vaccination [6]; NmA was detected in only
one carrier (0.02%) during a survey conducted 2 years
later (Figure 2a) [5]. In Chad, the prevalence of NmA
prior to vaccination was also low (<1%) but 4–6 months
after vaccination only one group A meningococcus was
found in the 5001 subjects studied (Figure 2b) [4]. In
Burkina Faso, there was an increase in NmX and NmY
carriage and in Chad an increase in the prevalence of car-
riage with capsule null N. meningitis following vaccina-
tion with MenAfriVacR. A study undertaken in 240
school-age children resident in an urban area near to
Addis Ababa, after national implementation of MenAfri-
VacR, and which employed nasopharyngeal rather than
oropharyngeal swabs found a high overall prevalence of
meningococcal carriage (20.4%) with a predominance of
serogroups W and C [23].
Molecular epidemiology of Neisseria species in the Afri-
can meningitis belt. The majority of the carriage isolates
of N. meningitidis identified during pre-MenAfriVacR
carriage surveys conducted in Burkina Faso were NmY
(457) [14]. Other serogroups identified in Burkina Faso
were NmW (70), NmX (90), NmA (80) and NmC [14].
One hundred and eight isolates were not serotypable.
Twenty-nine different sequence types, five different clonal
complexes and 51 PorA:FetA combinations were identi-
fied, allowing the characterisation of 68 distinct strain
types [defined as serogroup:PorA VR1,VR2:FetA VR: ST
(cc)]. The NmA isolates were all A:P1.20,9:F3-1:ST-2859
(cc5), the NmW were all from cc175, the NmC from
cc41/44, the NmY belonged to two different clonal com-
plexes (cc23 and cc167) while the NmX belonged to ST-
181, previously unassigned to any clonal complex.
Although multiple porA-fetA combinations were identi-
fied for all but serogroup A, one combination was found
in the majority of isolates for each serogroup suggesting
selection pressure for particular genetic traits. The sur-
veys conducted in the same sites a year after MenAfri-
VacR vaccination identified mostly NmX belonging to
ST-181 (5.33% of the samples) [14]. Two years after
MenAfriVacR vaccination, NmW from ST-11 cc domi-
nated with a carriage prevalence of 6.85% [5].T
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In Ethiopia, a carriage study undertaken prior to the
introduction of MenAfriVacR found a predominance of
non-capsulated meningococci identified as ST-192; the
two other serogroups identified most frequently were
NmX from cc181 and cc41/44, and NmW from the
hypervirulent cc11 clonal complexes. Low carriage preva-
lences of NmC:cc103 and NmY:cc167 meningococci
were also identified. No NmA was detected. The diversity
of the isolates remained low but higher than that
recorded in the Burkina Faso studies [18].
The characterisation method used in the MenAfriCar
studies did not include MLST; instead, sequencing of a
fragment of the rplF ribosomal locus was conducted to
identify the meningococcus, followed by PorA VR1 and
VR2 finetyping and genogrouping by PCR and cnl sequenc-
ing [25]. The most frequently identified meningococci were
non-capsulated followed by NmWwith a prevalence of
1.3%. A total of 132 strain types, defined as the combina-
tion of the genogroup and porA subtype, were identified;
the most frequently identified were cnl:P1.18-11,42-11,
usually associated with ST-192, andNmW:P1.5,2, usually
associated with the hypervirulent cc11 [16].
Post MenAfriVacR vaccination changes included a
marked increase in the overall prevalence of the cnl:
P1.18-11,42-1 strain in Chad [4] and an expansion of the
Nm W:P1.5,2 strain in Mali and Niger [16].
Few studies of whole genome sequencing of meningo-
coccal carriage isolates obtained in the African meningitis
belt have been reported. A study of NmA isolates, includ-
ing both carriage and invasive isolates, collected during
an epidemic in Chad demonstrated differences between
closely related strains that were indistinguishable by
MLST analysis [21]. The bacterial clusters identified were
linked to age group but did not differ between carriage
and invasive disease isolates. A study from Ethiopia com-
pared the genomes of paired isolates collected at an inter-
val of 2 months within the same 50 individuals and
showed changes in genes belonging to the pilin family,
the restriction/modification systems, the opacity proteins
and genes involved in glycosylation [22].
Carriage of non-meningococcal Neisseria species. Three
studies investigated carriage with non-meningococcalNeis-
seria species, two focussed only onN. lactamicawhilst the
third studied the prevalence of additionalNeisseria species.
In Burkina Faso, the prevalence of N. lactamica in 1–29
year olds in 45 847 samples obtained during nine carriage
surveys conducted from 2009 to 2011 was remarkably
constant at about 20% and differed little between three
study sites [13]. The carriage rate peaked at a prevalence of
40.1% in 2 year olds and then fell progressively to about
10% in 10–29 year olds. Carriage ofN. lactamica wasT
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slightly more prevalent in males than in females
(OR = 1.11 [95% CI: 1.04–1.18]) but the carriage rate did
not vary by season or change following the introduction of
MenAfriVacR. MLST was applied to a selection of N. lac-
tamica isolates; however, high genetic diversity was
observed with 62 different genotypes identified [13].
Carriage of N. lactamica was also studied in a rural
community in Ethiopia in 2014 [18]. The prevalence of
carriage in subjects aged 1–29 years was similar to that
seen in Burkina Faso (28.1%) but, unlike the situation in
Burkina Faso, varied significantly among districts (kebe-
les). The highest prevalence of carriage (54.5%) was seen
in 1-year-old children. No difference was found between
genders and there was no evidence of an interaction
between N. lactamica and N. meningitidis.
During the course of the MenAfriCar surveys conducted
in seven meningitis belt countries, non-meningococcal
Neisseria were detected in 3,015 of 46 034 (6.6%) pha-
ryngeal swabs [17]. Neisseria lactamica was the most fre-
quently isolated non-meningococcal Neisseria species,
with an overall prevalence of 5.6% (95% CI 5.3, 5.8) in
all age groups and a peak prevalence of 14.0% in those
aged 1–4 years. Prevalence varied significantly among
countries from 1.9% (95% CI: 1.6, 2.2) in Mali to 13.3%
(95% CI: 12.5, 14.10) in Niger. Small numbers of other
non-meningococcal Neisseria were isolated – Neisseria
Records identified in WoS
(n = 84)
Records identified in PubMed
(n = 71)
Records after duplicates removed
(n = 127)
Titles screened
(n = 112)
Records excluded
(n = 76)
Full-text articles assessed 
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(n = 36)
Full-text articles excluded, with 
reasons
(n = 13)
6had been included in 2007 review
1 was about rapid diagnostic tests
1 recruited only HIV infected individuals
1 did not include carriage data
Studies included in review 
of carriage epidemiology
(n = 20)
Studies of carriage 
methodology
(n = 3)
1 additional study 
identified (Sie et al, 2008)
Figure 1 Search methods employed to identify papers published since 2007 relevant to carriage of meningococci in the African menin-
gitis belt.
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polysaccharea (290), Neisseria bergeri (113) and Neisseria
subflava (24). Neisseria polysaccharea was found most fre-
quently in Ethiopia whilst N. bergeri and N. subflava were
isolated most frequently in Chad. Significant risk factors
for carriage of any non-meningococcal Neisseria species
included age, gender and season [17]. Carriage was less
prevalent in males than in females (RRR = 0.87 [0.80,
0.94]) and less prevalent in the dry season than in the rainy
season (RRR = 0.78 [0.70, 0.86]), in contrast to carriage
of N. meningitidis which was more prevalent in the dry
season (RRR = 1.53 [1.35, 1.74]). Molecular characterisa-
tion of the non-meningococcal Neisseria species using a
combination of Sanger sequencing of a fragment of the
rplF locus and of the variable region of the fetA locus iden-
tified five different Neisseria species and 636 combinations
of rplF-FetA VR, highlighting the large diversity of the
Neisseria species identified in the region [17].
Discussion
This review has brought together the results of meningo-
coccal carriage surveys conducted in the African meningi-
tis reported since 2007. In comparison with earlier
studies, whose methods were very varied, these surveys
used very similar field and laboratory methods allowing
more reliable comparisons of changes in the pattern of
meningococcal carriage in time and place than was the
case in the period prior to the 2007 review.
The combined results of a large number of surveys are
largely in agreement with the main findings of the earlier
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
pre-5 pre-4 pre-3 pre-2 pre-1 post1
0,39%
MenAfriVac
vaccination
Bogodogo district
Ca
rri
ag
e 
pr
ev
a
le
nc
e 
of
 s
er
og
ro
u
p 
A 
N
ei
ss
er
ia
m
e
n
in
gi
tid
is 
(%
)
Kaya district
Overall Prevalence
Dandé district
0,00%
post2 post3 post4 post5
0
0
1
2
13–15 months 2–4 months 4–6 months
1
All meningococci
Epidemic strainVACCINATION
Pre-vaccination Post-vaccination
Percentage
carriage
32
(a)
(b)
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studies, in particular the marked differences in the
prevalence and serogroup distribution of meningococcal
carriage between adjacent sites and over time at the
same site. As noted in previous studies, carriage was
seen most frequently in those aged 5–14 years, in males
more frequently than in females and in those exposed to
smoke or a respiratory infection. A new epidemiological
finding, not identified clearly in previous studies, was a
modest increase in the prevalence of carriage in the dry
season, noted in four studies, suggesting an increase in
transmission at this time of the year. This could con-
tribute to the seasonal nature of epidemics, as suggested
by a mathematical model [29] although it is likely that
other microbiological, environment and social factors
also play a significant role in the generation of epi-
demics.
The prevalence of meningococcal carriage varied mark-
edly between surveys but the mean carriage prevalence of
4.4% obtained across the surveys conducted prior to the
deployment of MenAfriVac was lower than that found
in most surveys conducted in industrialised countries [30]
suggesting that the force of infection is less in the African
meningitis belt than in industrialised countries resulting
in less naturally acquired immunity and a predisposition
to epidemics. This hypothesis is supported by the fact
that the diversity of carriage isolates was less in countries
of the meningitis belt, especially those in the centre of the
meningitis belt, than usually found in industrialised coun-
tries. However, the mean duration of carriage detected in
a household study was approximately 3 months, a similar
duration to that obtained in an earlier study in Nigeria
[31], substantially less than that usually found in carriage
studies conducted in industrialised countries [32]. This
provides a potential explanation of why the prevalence of
meningococcal carriage is lower in meningitis belt than in
industrialised countries.
As reported previously, the prevalence of group A
meningococcal carriage was reduced substantially follow-
ing the introduction of MenAfriVac in Burkina Faso
and Chad, and the impact on this vaccine on carriage is
likely to have contributed to profound reductions in
group A disease observed across the belt since
MenAfriVac roll-out [33].
Little was known previously about the pattern of trans-
mission of N. meningitidis in African meningitis belt
countries. The MenAfriCar study undertaken in five
countries found strong evidence for transmission within
and outside households [19]. This provided important
new information of relevance to potential control inter-
ventions. For example, it supports the results from a
recently conducted village randomised trial of chemopro-
phylaxis which showed that village-wide but not
household-targeted prophylaxis was effective in reducing
the meningitis attack rate [34].
New molecular methods of detecting and characterising
Neisseria species have become available since the time of
the 2007 review [7]. Nevertheless, all the studies con-
ducted since that time have used conventional microbio-
logical methods for the primary identification of
N. meningitidis but the majority have then used molecu-
lar methods to characterise these further including deter-
mining capsular group. Several studies reported a lack of
congruence between typing by the conventional aggluti-
nation method and PCR and the former method, which
requires skill and experience, is likely to become only sec-
ond choice for grouping as access to PCR become more
widely available. The size and cost of such surveys could
be reduced if more sensitive methods of detecting
meningococci in the pharynx could be developed. Thus,
the results of a pilot study conducted in The Gambia
which used preliminary culture of a swab in broth fol-
lowed by PCR as a supplement to the conventional
microbiological approach is important as this showed the
broth culture method was substantially more sensitive
than conventional culture [20]. Similar approaches,
including direct isolation of DNA from swabs, are likely
to be used increasingly frequently in surveys conducted in
the meningitis belt. Molecular methods also have the
advantage of allowing quantitation of the density of car-
riage, a factor that could be important in determining the
likelihood of transmission.
Because the carriage prevalence of N. meningitidis is
generally low, and conventional isolation techniques rela-
tively insensitive, large studies are needed to measure it
precisely and to make comparisons among groups, for
example, those in vaccine trials. The introduction of new,
potentially more sensitive diagnostic methods may help
to reduce required sample sizes, but conducting high
quality carriage surveys will still be demanding, especially
in settings where technical and financial resources are
constrained. For these reasons it is important to demon-
strate the potential value of carriage studies, especially in
areas with few resources, such as the African meningitis
belt. An important role for carriage studies, especially
when performed together with molecular characterisation
of meningococcal isolates, is identification of patterns of
transmission of N. meningitidis. Remarkably, few such
studies have been undertaken to date and yet this infor-
mation would be of very valuable in the rational plan-
ning of vaccination and/or chemoprophylaxis
interventions. A second key role for carriage studies is
determining the impact on carriage of novel vaccines,
such as the pentavalent meningococcal conjugate vaccine
currently under evaluation. It is now clear that the ability
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to prevent pharyngeal acquisition of meningococci is a
key attribute of conjugate vaccines and that vaccines that
are unable to do this will be less effective than those that
can. Finally, comparison of representative carriage and
disease isolates that have been characterised in detail with
molecular methods, including WGS, provide important
information on the epidemiology, genetics and pathogen-
esis of the meningococcus. These data will be essential in
understanding how hyperinvasive meningococci evolve.
The majority of carriage studies have focussed on
N meningitidis alone (with a minority also including
N lactamica). More recent studies have shown that this
bacterium is only one of a number of Neisseria species
resident in the pharynx of inhabitants of the meningitis
belt. The prevalence of these bacteria also varies by time
and space.
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